Cancer Control Program, Georgetown University — Washington D.C., District of Columbia

Cancer Control Program, Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Control Program, Georgetown University has participated in 1 clinical trials.

Therapeutic areas: Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline.

Sponsors: Georgetown University.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Control Program, Georgetown University?

Cancer Control Program, Georgetown University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Control Program, Georgetown University conducted?

Cancer Control Program, Georgetown University has 1 clinical trials on record. Their work covers Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline.

Is Cancer Control Program, Georgetown University accredited by Crixeo Health?

Cancer Control Program, Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Control Program, Georgetown University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.